The effects of lycopene on the methylation of the GSTP1 promoter and global methylation in prostatic cancer cell lines PC3 and LNCaP

International Journal of Endocrinology

Volumn 2014, Issue , 2014, Pages

  Fu, Li Juan ^a   Ding, Yu Bin ^a   Wu, Lan Xiang ^a   Wen, Chun Jie ^a   Qu, Qiang ^b   Zhang, Xue ^a   Zhou, Hong Hao ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; DNA METHYLTRANSFERASE 1; DNA METHYLTRANSFERASE 3A; DNA METHYLTRANSFERASE 3B; GLUTATHIONE TRANSFERASE P1; LYCOPENE; MESSENGER RNA;

ARTICLE; CELL LEVEL; CONTROLLED STUDY; DNA METHYLATION; DOWN REGULATION; DRUG EFFECT; HUMAN; HUMAN CELL; LNCAP CELL LINE; LONG INTERSPERSED REPEAT; PC3 CELLL LINE; PROMOTER REGION; PROSTATE CANCER CELL LINE; PROTEIN EXPRESSION; SHORT INTERSPERSED REPEAT;

EID: 84911445517     PISSN: 16878337     EISSN: 16878345     Source Type: Journal    
DOI: 10.1155/2014/620165     Document Type: Article

References (36)

1. Jemal A., Siegel R., Xu J., Ward E., Cancer statistics, 2010. CA Cancer Journal for Clinicians 2010 60 5 277 300 10.3322/caac.20073 2-s2.0-77955635233
2. Nelson W. G., de Marzo A. M., Yegnasubramanian S., Epigenetic alterations in human prostate cancers. Endocrinology 2009 150 9 3991 4002 10.1210/en.2009-0573 2-s2.0-69249119942
3. Lee W.-H., Morton R. A., Epstein J. I., Brooks J. D., Campbell P. A., Bova G. S., Hsieh W.-S., Isaacs W. B., Nelson W. G., Cytidine methylation of regulatory sequences near the π -class glutathione S-transferase gene accompanies human prostatic carcinogenesis. Proceedings of the National Academy of Sciences of the United States of America 1994 91 24 11733 11737 10.1073/pnas.91.24.11733 2-s2.0-0028152397
4. Lin X., Tascilar M., Lee W.-H., Vles W. J., Lee B. H., Veeraswamy R., Asgari K., Freije D., Van Rees B., Gage W. R., Bova G. S., Isaacs W. B., Brooks J. D., Deweese T. L., De Marzo A. M., Nelson W. G., GSTP1 CpG island hypermethylation is responsible for the absence of GSTP1 expression in human prostate cancer cells. The American Journal of Pathology 2001 159 5 1815 1826 10.1016/S0002-9440(10)63028-3 2-s2.0-0035152120
5. Wu T., Giovannucci E., Welge J., Mallick P., Tang W.-Y., Ho S.-M., Measurement of GSTP1 promoter methylation in body fluids may complement PSA screening: a meta-analysis. British Journal of Cancer 2011 105 1 65 73 10.1038/bjc.2011.143 2-s2.0-79959686697
6. Brooks J. D., Weinstein M., Lin X., Sun Y., Pin S. S., Bova G. S., Epstein J. I., Isaacs W. B., Nelson W. G., CG island methylation changes near the GSTP1 gene in prostatic intraepithelial neoplasia. Cancer Epidemiology Biomarkers and Prevention 1998 7 6 531 536 2-s2.0-0031879694
7. Nakayama M., Bennett C. J., Hicks J. L., Epstein J. I., Platz E. A., Nelson W. G., De Marzo A. M., Hypermethylation of the human glutathione S-transferase- π gene (GSTP1) CpG island is present in a subset of proliferative inflammatory atrophy lesions but not in normal or hyperplastic epithelium of the prostate: a detailed study using laser-capture microdissection. American Journal of Pathology 2003 163 3 923 933 10.1016/S0002-9440(10)63452-9 2-s2.0-0041924823
8. Meiers I., Shanks J. H., Bostwick D. G., Glutathione S-transferase pi (GSTP1) hypermethylation in prostate cancer: review 2007. Pathology 2007 39 3 299 304 10.1080/00313020701329906 2-s2.0-34250220644
9. Nelson C. P., Kidd L. C. R., Sauvageot J., Isaacs W. B., De Marzo A. M., Groopman J. D., Nelson W. G., Kensler T. W., Protection against 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine cytotoxicity and DNA adduct formation in human prostate by Glutathione S-Transferase P1. Cancer Research 2001 61 1 103 109 2-s2.0-0035138171
10. Henderson C. J., Smith A. G., Ure J., Increased skin tumorigenesis in mice lacking pi class glutathione S-transferases. Proceedings of the National Academy of Sciences of the United States of America 1998 75 5275 5280
11. Yoo C. B., Cheng J. C., Jones P. A., Zebularine: a new drug for epigenetic therapy. Biochemical Society Transactions 2004 32 6 910 912 10.1042/BST0320910 2-s2.0-10644256532
12. Davis C. D., Uthus E. O., DNA methylation, cancer susceptibility, and nutrient interactions. Experimental Biology and Medicine 2004 229 10 988 995 2-s2.0-7244221348
13. Nandakumar V., Vaid M., Katiyar S. K., (-)-Epigallocatechin-3-gallate reactivates silenced tumor suppressor genes, Cip1/p21 and p16INK4a, by reducing DNA methylation and increasing histones acetylation in human skin cancer cells. Carcinogenesis 2011 32 4 537 544 10.1093/carcin/bgq285 2-s2.0-79953692105
14. Fu S., Kurzrock R., Development of curcumin as an epigenetic agent. Cancer 2010 116 20 4670 4676 10.1002/cncr.25414 2-s2.0-78349269863
15. Pandey M., Shukla S., Gupta S., Promoter demethylation and chromatin remodeling by green tea polyphenols leads to re-expression of GSTP1 in human prostate cancer cells. International Journal of Cancer 2010 126 11 2520 2533 10.1002/ijc.24988 2-s2.0-77951225012
16. Najm W., Lie D., Dietary supplements commonly used for prevention. Primary Care-Clinics in Office Practice 2008 35 4 749 767 10.1016/j.pop.2008.07.010 2-s2.0-53349129570
17. Ansari M. S., Sgupta N. P., A comparison of lycopene and orchidectomy vs orchidectomy alone in the management of advanced prostate cancer. BJU International 2005 95 3 453 10.1111/j.1464-410X.2005.05368.x 2-s2.0-14144249403
18. Ansari M. S., Ansari S., Lycopene and prostate cancer. Future Oncology 2005 1 3 425 430 10.1517/14796694.1.3.425 2-s2.0-33646451396
19. Lu Q.-Y., Hung J.-C., Heber D., Go V. L. W., Reuter V. E., Cordon-Cardo C., Scher H. I., Marshall J. R., Zhang Z.-F., Inverse associations between plasma lycopene and other carotenoids and prostate cancer. Cancer Epidemiology Biomarkers and Prevention 2001 10 7 749 756 2-s2.0-0034915328
20. Gann P. H., Ma J., Giovannucci E., Willett W., Sacks F. M., Hennekens C. H., Stampfer M. J., Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis. Cancer Research 1999 59 6 1225 1230 2-s2.0-0033559952
21. Kucuk O., Sarkar F. H., Djuric Z., Sakr W., Pollak M. N., Khachik F., Banerjee M., Bertram J. S., Wood D. P. Jr., Effects of lycopene supplementation in patients with localized prostate cancer. Experimental Biology and Medicine 2002 227 10 881 885 2-s2.0-0036847259
22. King-Batoon A., Leszczynska J. M., Klein C. B., Modulation of gene methylation by genistein or lycopene in breast cancer cells. Environmental and Molecular Mutagenesis 2008 49 1 36 45 10.1002/em.20363 2-s2.0-39749140314
23. Lin C.-Y., Huang C.-S., Hu M.-L., The use of fetal bovine serum as delivery vehicle to improve the uptake and stability of lycopene in cell culture studies. The British Journal of Nutrition 2007 98 1 226 232 10.1017/S0007114507691752 2-s2.0-34547970907
24. Gonzalgo M. L., Pavlovich C. P., Lee S. M., Nelson W. G., Prostate cancer detection by GSTP1 methylation analysis of postbiopsy urine specimens. Clinical Cancer Research 2003 9 7 2673 2677 2-s2.0-0037817323
25. Yang A. S., Estécio M. R. H., Doshi K., Kondo Y., Tajara E. H., Issa J.-P. J., A simple method for estimating global DNA methylation using bisulfite PCR of repetitive DNA elements. Nucleic Acids Research 2004 32 3, article e38 10.1093/nar/gnh032 2-s2.0-2342557977
26. Livak K. J., Schmittgen T. D., Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method. Methods 2001 25 4 402 408 10.1006/meth.2001.1262 2-s2.0-0035710746
27. Bakker J., Lin X., Nelson W. G., Methyl-CpG binding domain protein 2 represses transcription from hypermethylated π -class glutathione S-transferase gene promoters in hepatocellular carcinoma cells. Journal of Biological Chemistry 2002 277 25 22573 22580 10.1074/jbc.M203009200 2-s2.0-0037151042
28. Li Y., Tollefsbol T. O., Impact on DNA methylation in cancer prevention and therapy by bioactive dietary components. Current Medicinal Chemistry 2010 17 20 2141 2151 10.2174/092986710791299966 2-s2.0-77955621544
29. Chen Z. X., Riggs A. D., DNA methylation and demethylation in mammal. Journal of Biological Chemistry 2011 286 21 18347 18353 10.1074/jbc.R110.205286 2-s2.0-79956294973
30. Cho N.-Y., Kim B.-H., Choi M., Yoo E. J., Moon K. C., Cho Y.-M., Kim D., Kang G. H., Hypermethylation of CpG island loci and hypomethylation of LINE-1 and Alu repeats in prostate adenocarcinoma and their relationship to clinicopathological features. Journal of Pathology 2007 211 3 269 277 10.1002/path.2106 2-s2.0-33846639662
31. Huang J., Plass C., Gerhäuser C., Cancer chemoprevention by targeting the epigenome. Current Drug Targets 2011 12 13 1925 1956 10.2174/138945011798184155 2-s2.0-82055161827
32. Liu A. G., Erdman J. W. Jr., Lycopene and apo-10′-lycopenal do not alter DNA methylation of GSTP1 in LNCaP cells. Biochemical and Biophysical Research Communications 2011 412 3 479 482 10.1016/j.bbrc.2011.07.124 2-s2.0-84860398789
33. Ficz G., Hore T. A., Santos F., Lee H. J., Dean W., Arand J., Krueger F., Oxley D., Paul Y.-L., Walter J., Cook S. J., Andrews S., Branco M. R., Reik W., FGF signaling inhibition in ESCs drives rapid genome-wide demethylation to the epigenetic ground state of pluripotency. Cell Stem Cell 2013 13 3 351 359 10.1016/j.stem.2013.06.004 2-s2.0-84884164554
34. Kagiwada S., Kurimoto K., Hirota T., Yamaji M., Saitou M., Replication-coupled passive DNA demethylation for the erasure of genome imprints in mice. The EMBO Journal 2013 32 3 340 353 10.1038/emboj.2012.331 2-s2.0-84873570094
35. Ohno R., Nakayama M., Naruse C., Okashita N., Takano O., Tachibana M., Asano M., Saitou M., Seki Y., A replication-dependent passive mechanism modulates DNA demethylation in mouse primordial germ cells. Development 2013 140 14 2892 2903 10.1242/dev.093229 2-s2.0-84879745846
36. Wu H.-C., Delgado-Cruzata L., Flom J. D., Perrin M., Liao Y., Ferris J. S., Santella R. M., Terry M. B., Repetitive element DNA methylation levels in white blood cell DNA from sisters discordant for breast cancer from the New York site of the breast cancer family registry. Carcinogenesis 2012 33 10 1946 1952 10.1093/carcin/bgs201 2-s2.0-84864793380